ArticleNeuro-oncology advances

Phase I study of vinblastine in combination with nilotinib in children, adolescents, and young adults with refractory or recurrent low-grade glioma.

Stephanie Vairy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.